SCH 530348: a novel oral thrombin receptor antagonist

Future Cardiology ◽

10.2217/fca.09.27 ◽

2009 ◽

Vol 5 (5) ◽

pp. 435-442 ◽

Author(s):

Marc P Bonaca ◽

David A Morrow

Keyword(s):

Receptor Antagonist ◽

Thrombin Receptor ◽

Thrombin Receptor Antagonist

Download Full-text

Convergent Synthesis of Both Enantiomers of 4-Hydroxypent-2-ynoic Acid Diphenylamide for a Thrombin Receptor Antagonist Sch 530348 and Himbacine Analogues

Advanced Synthesis & Catalysis ◽

10.1002/adsc.200900322 ◽

2009 ◽

Vol 351 (14-15) ◽

pp. 2351-2357 ◽

Author(s):

Alex Zaks ◽

Maria Tamarez ◽

Tao Li

Keyword(s):

Receptor Antagonist ◽

Thrombin Receptor ◽

Convergent Synthesis ◽

Thrombin Receptor Antagonist

Download Full-text

Effect of Food, Antacid, and Age on the Pharmacokinetics of the Oral Thrombin Receptor Antagonist Vorapaxar (SCH 530348) in Healthy Volunteers

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.30 ◽

2013 ◽

Vol 2 (3) ◽

pp. 223-230 ◽

Author(s):

Teddy Kosoglou ◽

Larisa Reyderman ◽

Jack Tseng ◽

Bharath Kumar ◽

Fengjuan Xuan ◽

...

Keyword(s):

Healthy Volunteers ◽

Receptor Antagonist ◽

Thrombin Receptor ◽

Effect Of Food ◽

Thrombin Receptor Antagonist

Download Full-text

Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity

Journal of Medicinal Chemistry ◽

10.1021/jm800180e ◽

2008 ◽

Vol 51 (11) ◽

pp. 3061-3064 ◽

Author(s):

Samuel Chackalamannil ◽

Yuguang Wang ◽

William J. Greenlee ◽

Zhiyong Hu ◽

Yan Xia ◽

...

Keyword(s):

Receptor Antagonist ◽

Thrombin Receptor ◽

Antiplatelet Activity ◽

Orally Active ◽

Thrombin Receptor Antagonist

Download Full-text

Determination of a novel thrombin receptor antagonist (SCH 530348) in human plasma: Evaluation of Ultra Performance Liquid Chromatography™–tandem mass spectrometry for routine bioanalytical analysis

Journal of Pharmaceutical and Biomedical Analysis ◽

10.1016/j.jpba.2011.01.045 ◽

2011 ◽

Vol 55 (2) ◽

pp. 349-359 ◽

Author(s):

Cristina I. Tama ◽

Jim X. Shen ◽

James E. Schiller ◽

Roger N. Hayes ◽

Robert P. Clement

Keyword(s):

Mass Spectrometry ◽

Liquid Chromatography ◽

Tandem Mass Spectrometry ◽

Receptor Antagonist ◽

Ultra Performance Liquid Chromatography ◽

Thrombin Receptor ◽

Tandem Mass ◽

Thrombin Receptor Antagonist

Download Full-text

Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non–ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial)

The American Journal of Cardiology ◽

10.1016/j.amjcard.2015.02.043 ◽

2015 ◽

Vol 115 (10) ◽

pp. 1325-1332 ◽

Author(s):

Jan H. Cornel ◽

Pierluigi Tricoci ◽

Yuliya Lokhnygina ◽

David J. Moliterno ◽

Lars Wallentin ◽

...

Keyword(s):

Receptor Antagonist ◽

Acute Coronary Syndromes ◽

Thrombin Receptor ◽

St Segment Elevation ◽

Coronary Syndromes ◽

Thrombin Receptor Antagonist

Download Full-text

Effect of age on efficacy and safety of vorapaxar in patients with non–ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

American Heart Journal ◽

10.1016/j.ahj.2016.05.012 ◽

2016 ◽

Vol 178 ◽

pp. 176-184 ◽

Author(s):

Luciana V. Armaganijan ◽

Karen P. Alexander ◽

Zhen Huang ◽

Pierluigi Tricoci ◽

Claes Held ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Receptor Antagonist ◽

Clinical Event ◽

Thrombin Receptor ◽

Efficacy And Safety ◽

St Segment Elevation ◽

Coronary Syndrome ◽

Thrombin Receptor Antagonist ◽

Download Full-text

Inhibitory effects of FR171113, a novel, thrombin receptor antagonist, on platelet aggregation and thrombosis model in guinea-pigs

The Japanese Journal of Pharmacology ◽

10.1016/s0021-5198(19)40542-8 ◽

1998 ◽

Vol 76 ◽

pp. 106

Author(s):

Yasuko Kato ◽

Yasuhiro Kita ◽

Mie Nishio ◽

Yoshimi Hirasawa ◽

Kayoko Senzaki ◽

...

Keyword(s):

Platelet Aggregation ◽

Receptor Antagonist ◽

Guinea Pigs ◽

Thrombin Receptor ◽

Inhibitory Effects ◽

Thrombosis Model ◽

Thrombin Receptor Antagonist

Download Full-text

The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA•CER) trial: study design and rationale

American Heart Journal ◽

10.1016/j.ahj.2009.07.001 ◽

2009 ◽

Vol 158 (3) ◽

pp. 327-334.e4 ◽

Author(s):

The TRA•CER Executive and Steering Committees

Keyword(s):

Acute Coronary Syndrome ◽

Receptor Antagonist ◽

Study Design ◽

Clinical Event ◽

Thrombin Receptor ◽

Coronary Syndrome ◽

Thrombin Receptor Antagonist

Download Full-text

Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA{middle dot}CER) trial

European Heart Journal ◽

10.1093/eurheartj/eht104 ◽

2013 ◽

Vol 34 (23) ◽

pp. 1723-1731 ◽

Author(s):

S. Leonardi ◽

P. Tricoci ◽

H. D. White ◽

P. W. Armstrong ◽

Z. Huang ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndrome ◽

Receptor Antagonist ◽

Clinical Event ◽

Thrombin Receptor ◽

Coronary Syndrome ◽

Thrombin Receptor Antagonist

Download Full-text

Development of Potent Thrombin Receptor Antagonist Peptides

Journal of Medicinal Chemistry ◽

10.1021/jm960455s ◽

1996 ◽

Vol 39 (25) ◽

pp. 4879-4887 ◽

Author(s):

Michael S. Bernatowicz ◽

Clifford E. Klimas ◽

Karen S. Hartl ◽

Marianne Peluso ◽

Nick J. Allegretto ◽

...

Keyword(s):

Receptor Antagonist ◽

Thrombin Receptor ◽

Antagonist Peptides ◽

Thrombin Receptor Antagonist

Download Full-text